{
  "company": {
    "name": "Modulight Biotherapeutics",
    "website": "https://modulight.bio/",
    "record": "https://startuphistory.org/c/modulight.bio"
  },
  "status": null,
  "history_since": "2023-12-28T18:14:12.000Z",
  "baseline": {
    "snapshot_id": "5728e1bd19777053f301ad21b1006cc448fe001e10e273f6b8e914205b57a57a",
    "observed_at": "2023-12-28T18:14:12.000Z",
    "headline": "Hyper-sensitive synapse switches",
    "description": "ModuLight was founded to develop therapeutic treatments for severe neurological syndromes including drug-resistant focal epilepsy, Parkinson’s, and severe neuropathic pain syndromes using groundbreaki",
    "evidence": "https://web.archive.org/web/20231228181412/https://www.modulight.bio/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:44:22.965Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2024-02-01T08:35:47.000Z",
      "variants": [
        {
          "headline": "Hyper-sensitive synapse switches",
          "subhead": "ModuLight was founded to develop therapeutic treatments for severe neurological syndromes including drug-resistant focal epilepsy, Parkinson’s, and severe neuropathic pain syndromes using groundbreaki",
          "observed_at": "2023-12-28T18:14:12.000Z",
          "evidence": "https://web.archive.org/web/20231228181412/https://www.modulight.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Hyper-sensitive synapse switches",
          "subhead": "ModuLight was founded to develop therapeutic treatments for severe neurological syndromes including drug-resistant focal epilepsy, Parkinson’s, and severe neuropathic pain syndromes using groundbreaki",
          "observed_at": "2024-02-01T08:35:47.000Z",
          "evidence": "https://web.archive.org/web/20240201083547/https://www.modulight.bio/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Hyper-sensitive synapse switches",
      "subhead": "ModuLight was founded to develop therapeutic treatments for severe neurological syndromes including drug-resistant focal epilepsy, Parkinson’s, and severe neuropathic pain syndromes using groundbreaki",
      "from": "2023-12-28T18:14:12.000Z",
      "to": "2024-02-01T08:35:47.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20240201083547/https://www.modulight.bio/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2023-12-28T18:14:12.000Z",
          "to": "2024-02-01T08:35:47.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:44:22.965Z",
      "variants": [
        {
          "headline": "Restoring Balance, Transforming Neurology",
          "subhead": "Illuminating the path to precision brain therapies",
          "observed_at": "2024-07-20T17:12:19.000Z",
          "evidence": "https://web.archive.org/web/20240720171219/https://www.modulight.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Restoring Balance, Transforming Neurology",
          "subhead": "Illuminating the path to precision brain therapies",
          "observed_at": "2025-01-04T15:34:38.000Z",
          "evidence": "https://web.archive.org/web/20250104153438/https://www.modulight.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Restoring Balance, Transforming Neurology",
          "subhead": null,
          "observed_at": "2026-10-24T04:53:12.000Z",
          "evidence": "https://web.archive.org/web/20261024045312/https://www.modulight.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Restoring Balance, Transforming Neurology",
          "subhead": null,
          "observed_at": "2026-11-06T17:44:22.965Z",
          "evidence": "https://www.modulight.bio/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Restoring Balance, Transforming Neurology",
      "subhead": null,
      "from": "2024-07-20T17:12:19.000Z",
      "to": "2026-11-06T17:44:22.965Z",
      "captures": 4,
      "evidence": "https://www.modulight.bio/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2024-07-20T17:12:19.000Z",
          "to": "2026-11-06T17:44:22.965Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-76c703c250d365eadc9cc76c2e4341a41de4e73c042915c374badb3beb4b94c8:c77eb226753959f837c0ec1e9fca193533e4ce7994ebc0693165abbad6c6ab61:headline:0d05f2d86af32d89",
      "before_evidence": "https://web.archive.org/web/20240201083547/https://www.modulight.bio/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Hyper-sensitive synapse switches” to “Restoring Balance, Transforming Neurology”.",
      "between": {
        "from": "2024-02-01T08:35:47.000Z",
        "to": "2024-07-20T17:12:19.000Z"
      },
      "evidence": "https://web.archive.org/web/20240720171219/https://www.modulight.bio/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 2,
      "id": "page-62a1bfa46f7e7cf62b4866b2179419f641b1330889b0a48918ebfb80770ee992:ca4e5dafcdbe2a4614fcff4f4d3bf0a144bded85c0f6109351d0b576914eab28:funding:1bd40e5c71e93ec1",
      "before_evidence": "https://web.archive.org/web/20260123201641/https://www.modulight.bio/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “(2025) Read More \"Modulight Biotherapeutics announces $12 million seed funding for novel optogenic therapy to treat neurological disorder…”.",
      "between": {
        "from": "2026-01-23T20:16:41.000Z",
        "to": "2026-10-24T04:53:12.000Z"
      },
      "evidence": "https://web.archive.org/web/20261024045312/https://www.modulight.bio/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Modulight Biotherapeutics” company record, https://startuphistory.org/c/modulight.bio"
}